Benjamin Robert Puliafito, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5659 | 0.490 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1539 | 0.430 |
Why?
|
Transplantation, Autologous | 3 | 2022 | 2120 | 0.310 |
Why?
|
Graft vs Host Disease | 1 | 2021 | 3026 | 0.300 |
Why?
|
Multiple Myeloma | 2 | 2022 | 5131 | 0.290 |
Why?
|
Melphalan | 2 | 2022 | 421 | 0.230 |
Why?
|
Natural Killer T-Cells | 1 | 2024 | 311 | 0.180 |
Why?
|
Acute Chest Syndrome | 1 | 2020 | 32 | 0.170 |
Why?
|
Sickle Cell Trait | 1 | 2020 | 85 | 0.170 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 195 | 0.160 |
Why?
|
beta-Thalassemia | 1 | 2020 | 235 | 0.150 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 243 | 0.140 |
Why?
|
Microsatellite Instability | 1 | 2019 | 715 | 0.130 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2016 | 346 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 380 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1455 | 0.120 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4815 | 0.100 |
Why?
|
Chromosome Deletion | 1 | 2016 | 1387 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 1 | 2024 | 3390 | 0.100 |
Why?
|
Vaccination | 1 | 2021 | 3359 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1846 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11713 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9278 | 0.060 |
Why?
|
Heterozygote | 2 | 2020 | 2798 | 0.050 |
Why?
|
Carmustine | 1 | 2022 | 138 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9591 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2016 | 3193 | 0.050 |
Why?
|
Etoposide | 1 | 2022 | 630 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9406 | 0.050 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2020 | 59 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6853 | 0.040 |
Why?
|
Femur Head Necrosis | 1 | 2020 | 132 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8985 | 0.040 |
Why?
|
Schizophrenia | 1 | 2016 | 6915 | 0.040 |
Why?
|
Neurons | 1 | 2016 | 9424 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 404 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2022 | 2222 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 429 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 464 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3583 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 2536 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
Humans | 7 | 2024 | 760613 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1842 | 0.020 |
Why?
|
Male | 3 | 2022 | 359718 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1741 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16932 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3617 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8055 | 0.020 |
Why?
|
Young Adult | 2 | 2020 | 58748 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15620 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36053 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81209 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42056 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22075 | 0.010 |
Why?
|
Animals | 1 | 2024 | 167960 | 0.010 |
Why?
|
Child | 1 | 2019 | 79799 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 87809 | 0.010 |
Why?
|
Brain | 1 | 2016 | 26951 | 0.010 |
Why?
|
Middle Aged | 1 | 2022 | 220359 | 0.000 |
Why?
|
Adult | 1 | 2019 | 220007 | 0.000 |
Why?
|
Female | 1 | 2019 | 391246 | 0.000 |
Why?
|